Discovery Capital Management Has Cut Stake in Esperion Therapeutics Ord (ESPR) as Shares Rose; Texas Yale Capital Holds Holding in General Electric Co (GE)

February 19, 2018 - By Marie Mckinney

Texas Yale Capital Corp increased its stake in General Electric Co (GE) by 29.17% based on its latest 2017Q3 regulatory filing with the SEC. Texas Yale Capital Corp bought 15,500 shares as the company’s stock declined 7.64% while stock markets rallied. The institutional investor held 68,641 shares of the consumer electronics and appliances company at the end of 2017Q3, valued at $1.66 million, up from 53,141 at the end of the previous reported quarter. Texas Yale Capital Corp who had been investing in General Electric Co for a number of months, seems to be bullish on the $130.52B market cap company. The stock increased 1.35% or $0.2 during the last trading session, reaching $15.05. About 64.72 million shares traded. General Electric Company (NYSE:GE) has declined 4.46% since February 19, 2017 and is downtrending. It has underperformed by 21.16% the S&P500.

Rob Citrone decreased its stake in Esperion Therapeutics Ord (ESPR) by 18.86% based on its latest 2017Q3 regulatory filing with the SEC. Discovery Capital Management Llc sold 182,000 shares as the company’s stock rose 33.24% with the market. The hedge fund run by Rob Citrone held 783,059 shares of the health care company at the end of 2017Q3, valued at $39.25M, down from 965,059 at the end of the previous reported quarter. Discovery Capital Management Llc who had been investing in Esperion Therapeutics Ord for a number of months, seems to be less bullish one the $1.96 billion market cap company. The stock increased 0.46% or $0.34 during the last trading session, reaching $74.92. About 371,409 shares traded. Esperion Therapeutics, Inc. (NASDAQ:ESPR) has risen 133.75% since February 19, 2017 and is uptrending. It has outperformed by 117.05% the S&P500.

Among 28 analysts covering General Electric Company (NYSE:GE), 8 have Buy rating, 5 Sell and 15 Hold. Therefore 29% are positive. General Electric Company had 91 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of General Electric Company (NYSE:GE) has “Buy” rating given on Friday, July 7 by Stifel Nicolaus. The firm has “Buy” rating given on Monday, October 23 by Bank of America. The company was maintained on Monday, July 17 by Oppenheimer. The company was maintained on Monday, June 12 by Oppenheimer. The firm has “Hold” rating by Stifel Nicolaus given on Tuesday, January 30. The stock has “Neutral” rating by UBS on Monday, October 23. The firm has “Underweight” rating given on Wednesday, November 1 by JP Morgan. The firm has “Hold” rating by Cowen & Co given on Monday, July 17. The stock has “Buy” rating by Citigroup on Thursday, January 25. The rating was initiated by Standpoint Research on Friday, July 22 with “Sell”.

Texas Yale Capital Corp, which manages about $1.61B and $1.16 billion US Long portfolio, decreased its stake in Jpmorgan Chase & Co (NYSE:JPM) by 10,589 shares to 128,192 shares, valued at $12.24 million in 2017Q3, according to the filing. It also reduced its holding in Energy Transfer Equity LP (NYSE:ETE) by 18,860 shares in the quarter, leaving it with 569,935 shares, and cut its stake in Ishares Tr (SUB).

Investors sentiment decreased to 0.69 in Q3 2017. Its down 0.10, from 0.79 in 2017Q2. It worsened, as 112 investors sold GE shares while 818 reduced holdings. 118 funds opened positions while 525 raised stakes. 4.70 billion shares or 1.82% more from 4.61 billion shares in 2017Q2 were reported. Alpha Windward Ltd Liability reported 12,669 shares stake. Stanley reported 0.17% in General Electric Company (NYSE:GE). Wealthcare Mgmt accumulated 0% or 1,422 shares. Cypress Cap Grp invested in 0.83% or 160,525 shares. General Elec Comm owns 142,000 shares. 81,114 were reported by Boyar Asset Mngmt. Meridian Counsel Inc invested in 1.07% or 66,300 shares. Iowa Financial Bank invested 2.17% of its portfolio in General Electric Company (NYSE:GE). Partnervest Advisory Svcs Lc accumulated 0.26% or 22,153 shares. Aviance Capital Limited Liability Corp holds 0.03% or 18,787 shares in its portfolio. Counselors Incorporated invested in 0.76% or 642,240 shares. Confluence Wealth Mngmt Ltd reported 10,191 shares or 0.12% of all its holdings. Riverhead Capital Mgmt Limited Liability Corporation owns 73,192 shares. Cls Invests Ltd Liability has 0% invested in General Electric Company (NYSE:GE) for 293 shares. Woodstock holds 1.85% in General Electric Company (NYSE:GE) or 401,190 shares.

Since August 22, 2017, it had 1 buy, and 0 sales for $43,446 activity. TISCH JAMES S bought $2.46 million worth of General Electric Company (NYSE:GE) on Tuesday, August 22.

Discovery Capital Management Llc, which manages about $37.50B and $4.19B US Long portfolio, upped its stake in Sprint Corp (NYSE:S) by 849,152 shares to 27.48 million shares, valued at $213.78M in 2017Q3, according to the filing. It also increased its holding in Banco Macro Sa (NYSE:BMA) by 177,168 shares in the quarter, for a total of 338,168 shares, and has risen its stake in Grupo Financiero Galicia S A (NASDAQ:GGAL).

Analysts await Esperion Therapeutics, Inc. (NASDAQ:ESPR) to report earnings on February, 28. They expect $-1.80 EPS, down 39.53% or $0.51 from last year’s $-1.29 per share. After $-1.86 actual EPS reported by Esperion Therapeutics, Inc. for the previous quarter, Wall Street now forecasts -3.23% EPS growth.

Investors sentiment increased to 1.67 in Q3 2017. Its up 0.45, from 1.22 in 2017Q2. It is positive, as 11 investors sold ESPR shares while 34 reduced holdings. 30 funds opened positions while 45 raised stakes. 22.73 million shares or 17.55% more from 19.33 million shares in 2017Q2 were reported. 83,357 are held by Sabby Ltd. Renaissance Tech Limited Co owns 14,500 shares for 0% of their portfolio. First Mercantile Trust stated it has 2,714 shares or 0.02% of all its holdings. Deutsche Bancorporation Ag reported 117,987 shares. Nationwide Fund Advsrs reported 22,952 shares. Moreover, Schwab Charles Invest Mngmt Inc has 0% invested in Esperion Therapeutics, Inc. (NASDAQ:ESPR) for 91,843 shares. Lord Abbett & Communications Ltd Limited Liability Company has invested 0.03% in Esperion Therapeutics, Inc. (NASDAQ:ESPR). 280 are held by Hall Laurie J Trustee. Guggenheim Capital Ltd accumulated 0.01% or 55,095 shares. 78,364 are owned by Price T Rowe Assocs Md. 14,217 were accumulated by Tiverton Asset. Partner Invest LP reported 0.43% of its portfolio in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Swiss Bank owns 34,300 shares or 0% of their US portfolio. California Public Employees Retirement Systems, California-based fund reported 48,158 shares. Manufacturers Life Ins Com The accumulated 13,095 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: